Fig. 2From: The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma – a Swedish population-based studyStacked cumulative probability of cancer-specific and other-cause death among AML patients aged 60–89 yearsBack to article page